Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy
Fallowfield, L, Gagnon, D, Zagari, M, Cella, D, Bresnahan, B, Littlewood, T J, McNulty, P, Gorzegno, G, Freund, MVolume:
87
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/sj.bjc.6600657
Date:
December, 2002
File:
PDF, 230 KB
english, 2002